Welgus Howard G. 4

4 · Arcutis Biotherapeutics, Inc. · Filed Jun 9, 2026

AI-generated summary of this filing

Updated Jun 10, 2026

Arcutis (ARQT) Director Howard G. Welgus Receives 22,445-Share Award

What Happened

Howard G. Welgus, a director of Arcutis Biotherapeutics (ARQT), was granted two awards on June 5, 2026: 5,778 shares (RSUs) and 16,667 derivative awards, for a combined 22,445 shares. Both were reported as acquired at $0.00 (no cash paid).
These awards are grants (code A on the Form 4), not open-market purchases or sales. They represent compensation for board service rather than a cash transaction.

Key Details

Transaction date: June 5, 2026; Form 4 filed June 9, 2026 (reporting date).
Award amounts and price: 5,778 RSUs @ $0.00; 16,667 derivative awards @ $0.00; total 22,445 shares.
Vesting/conditions: Per footnotes, the RSUs and the derivative awards vest 100% on the earlier of the first anniversary of the grant date (June 5, 2026 as noted) or immediately before the next annual meeting of stockholders, subject to continued service through the vesting date.
Shares owned after the transaction: not disclosed in the provided excerpt.
No sale, purchase, or exercise-for-cash reported; this is a compensation grant.

Context

RSU and derivative grants are common director compensation and do not require immediate cash outlay; they convert to shares upon vesting if service conditions are met.
Because this filing reports awards (not sales), it reflects compensation rather than an expressed view to buy or sell stock.

Form 4

Period: 2026-06-05

Director

Transactions

Award
Common Stock
[F1]
2026-06-05+5,778→ 38,378 total
Award
Stock Option (right to buy)
[F2]
2026-06-05+16,667→ 16,667 total
Exercise: $21.23Exp: 2036-06-05→ Common Stock (16,667 underlying)

Footnotes (2)

[F1]Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.
[F2]The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.

Signature

/s/ Latha Vairavan, as Attorney-in-Fact for Howard G. Welgus|2026-06-09

1 file